Story thread · 2 reports / 2 sources
Thyroid Drug Recall Most Serious; GLP-1s and Vitamin Deficiency; New T1D Guidelines
medpagetoday.com · 4h
How the coverage leans
Across 2 sources · syndicated copies counted once
(MedPage Today) -- The FDA designated Vitruvias Therapeutics' recall of a lot of 30-mg levothyroxine-liothyronine tablets (Thyroid Tablets) as Class I, its most serious classification. (USA Today) At least six major U.S. hospitals have shut down...
First report: FDA issues recall of thyroid medication citing ‘super potency’ — kiro7.com, 1d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.